1. Home
  2. BCBP vs MOLN Comparison

BCBP vs MOLN Comparison

Compare BCBP & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$9.96

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$3.93

Market Cap

154.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
MOLN
Founded
2000
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
154.2M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
BCBP
MOLN
Price
$9.96
$3.93
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$10.00
$8.38
AVG Volume (30 Days)
123.7K
5.2K
Earning Date
04-21-2026
05-12-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
N/A
N/A
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
$374.07
P/E Ratio
$39.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.31
$3.46
52 Week High
$11.71
$5.36

Technical Indicators

Market Signals
Indicator
BCBP
MOLN
Relative Strength Index (RSI) 46.39 48.77
Support Level $9.74 $3.65
Resistance Level $10.60 $3.96
Average True Range (ATR) 0.28 0.07
MACD 0.01 -0.01
Stochastic Oscillator 31.64 53.85

Price Performance

Historical Comparison
BCBP
MOLN

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: